April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Changes in the Expression of Proteome in the Aqueous Humor of Patients with Neovascular Age-Related Macular Degeneration
Author Affiliations & Notes
  • Hyewon Chung
    Ophthalmology, Konkuk University Medical Center, Seoul, Republic of Korea
  • Ja Young You
    Ophthalmology, Konkuk University Medical Center, Seoul, Republic of Korea
  • Hyung Chan Kim
    Ophthalmology, Konkuk University Medical Center, Seoul, Republic of Korea
  • Gum-Yong Kang
    Probiond Co., Ltd., Seoul, Republic of Korea
  • Hyung Soon Park
    Probiond Co., Ltd., Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  Hyewon Chung, None; Ja Young You, None; Hyung Chan Kim, None; Gum-Yong Kang, None; Hyung Soon Park, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 6685. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hyewon Chung, Ja Young You, Hyung Chan Kim, Gum-Yong Kang, Hyung Soon Park; Changes in the Expression of Proteome in the Aqueous Humor of Patients with Neovascular Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2011;52(14):6685. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Although the levels of several proteins and cytokines in aqueous humor (AH) have been reported to change in patients with neovascular age-related macular degeneration (AMD), the whole proteome changes in AH of these patients remain unknown. Therefore, profiling and characterization of the whole proteome of AH from patients with neovascular AMD in vivo were initiated to elucidate the novel molecular aspect of AMD and find new biomarkers associated with it.

Methods: : Samples of AH were collected from four patients with treatment-naïve neovascular AMD and four age and sex-matched patients undergoing cataract surgery (controls). Samples from patients were obtained before performing the first intravitreal injection of ranibizumab 0.5 mg and 1 month after the first injection of ranibizumab. Proteins from AH samples were quantified, separated with SDS-PAGE, and underwent enzymatic in-gel digestion. Nano-LC-ESI-MS/MS analysis was done to identify and quantify the AH proteomes. The study followed the tenets of the Declaration of Helsinki.

Results: : A total average of 601 and 473 proteins were identified in the AH of patients and controls. Levels of cytokeratin18 and 19 decreased in patients and increased markedly (1.3-8 fold) after treatment. Along with cytokeratin, desmoplakin, another marker of epithelial cells, increased remarkably after treatment. It was also found that autophagy-related protein 7, lysozyme, and cathepsin D increased 1.6-9 fold in patients and decreased significantly after treatment. Other proteins which had increased more than twofold in patients and then decreased after treatment included those related to stress response, antioxidant activity and proteasome. Among these, proteins such as complement factor B and H, gelsolin, collagen alpha, annexin A1, glutathione transferase and clusterin may be possible secretory proteins from the retinal pigment epithelium and/or retina.

Conclusions: : The present study demonstrates that the proteomic composition of AH of patients with neovascular AMD differed significantly from that of the controls. This experiment provides new potential biomarkers and therapeutic target proteins in AMD, including proteins related to cytokeratins and autophagy.

Keywords: age-related macular degeneration • proteomics • retinal pigment epithelium 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×